UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 368

Sortiert nach

1 Laboratory presentation and morphological characteristics of myelodysplastic syndromes

Leukemia research, 1997-04, Vol.21 (1), p.S1-S1

1997

Volltextzugriff (PDF)

1084 Self-expanding metallic ureteral stents and extra-anatomic bypasses. Are they really effective for resolution of complex ureteral obstruction in the long-term?

European urology supplements : official journal of the European Association of Urology, 2014-04, Vol.13 (1), p.e1084-e1084a

2014

Volltextzugriff (PDF)

117 A PHASE 3 STUDY OF LENALIDOMIDE VERSUS PLACEBO IN RBC TRANSFUSION-DEPENDENT (TD) PATIENTS WITH LOWER-RISK MDS WITHOUT DEL(5Q) UNRESPONSIVE OR REFRACTORY TO ERYTHROPOIESIS-STIMULATING AGENTS (ESAS)

Leukemia research, 2015-04, Vol.39, p.S60-S61

2015

Volltextzugriff (PDF)

118 A PHASE 2 STUDY OF AZACITIDINE AND EPOETIN-BETA IN UNTREATED RBC-TRANSFUSION DEPENDENT LOWER-RISK MDS PATIENTS

Leukemia research, 2015-04, Vol.39, p.S61-S61

2015

Volltextzugriff (PDF)

163 - DNA Repair Genes Transcriptome in Chronic Myelomonocytic Leukemia

Leukemia research, 2017-04, Vol.55, p.S100-S100

2017

Volltextzugriff (PDF)

171 A TWO-STEP APPROACH FOR THE ANALYSIS OF SPLICING GENES IN MYELODYSPLASTIC SYNDROMES WITH RING SIDEROBLASTS

Leukemia research, 2015-04, Vol.39, p.S87-S87

2015

Volltextzugriff (PDF)

First clinical implantation of the BCM 3.5 ventricular assist device (VAD)

European journal of cardio-thoracic surgery, 1991-01, Vol.5 (1), p.46-50

1991

Volltextzugriff (PDF)

206 IMPACT OF TP53 MUTATION ON OUTCOME OF MDS PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANT (HSCT). GESMD STUDY

Leukemia research, 2015-04, Vol.39, p.S102-S103

2015

Volltextzugriff (PDF)

207 HIGH RISK MDS PATIENTS SUITABLE FOR ALLOGENEIC TRANSPLANT: IMPACT ON TREATMENT SELECTED (AZA OR CHEMOTHERAPY) ON OUTCOME. SINGLE EXPERIENCE CENTER

Leukemia research, 2015-04, Vol.39, p.S103-S104

2015

Volltextzugriff (PDF)

244 MYELOFIBROSIS (MF) AS A PROGNOSTIC TOOL FOR OVERALL SURVIVAL IN MYELODYSPLASTIC SYNDROMES: A PROSPECTIVE EVALUATION INCLUDING MUTATIONAL ANALYSIS BY NEXT GENERATION SEQUENCING (NGS)

Leukemia research, 2015-04, Vol.39, p.S121-S122

2015

Volltextzugriff (PDF)

258 Down-regulation of DICER1, DROSHA and microRNAs in MSC from MDS compared to healthy controls

Leukemia research, 2011, Vol.35, p.S101-S101

2011

Volltextzugriff (PDF)

282 - Iron Overload Increases Oxidative Stress and Decreases Clonogenic Capacity of Cells in MDS Patients: Can be Restored after Deferasirox Treatment?

Leukemia research, 2017-04, Vol.55, p.S161-S162

2017

Volltextzugriff (PDF)

292 Analysis of renal tissue environment using quantitative proteomics techniques: Healthy tissue from donors vs healthy tissue from renal cell carcinoma kidneys

European urology supplements : official journal of the European Association of Urology, 2014-04, Vol.13 (1), p.e292-e292

2014

Volltextzugriff (PDF)

297 Prognostic impact of severe thrombocytopenia in low risk myelodysplastic syndrome

Leukemia research, 2011, Vol.35, p.S117-S117

2011

Volltextzugriff (PDF)

298 Chromosome 7 abnormalities in MDS

Leukemia research, 2011, Vol.35, p.S117-S118

2011

Volltextzugriff (PDF)

298 Utility of quantitative proteomics techniques to identify renal cell carcinoma biomarkers

European urology supplements : official journal of the European Association of Urology, 2014-04, Vol.13 (1), p.e298-e298a

2014

Volltextzugriff (PDF)

A 3 Terminal Parallel Connected Silicon Tandem Solar Cell

Energy procedia, 2016, Vol.92, p.644-651

2016

Volltextzugriff (PDF)

308 HIDDEN MDS: A PROSPECTIVE STUDY TO CONFIRM OR EXCLUDE MDS IN PATIENTS WITH ANEMIA OF UNCERTAIN ETIOLOGY

Leukemia research, 2015-04, Vol.39, p.S153-S153

2015

Volltextzugriff (PDF)

41 - Chronic GVHD Could Ameliorate the Impact of Adverse Somatic Mutations in Patients with Myelodysplastic Syndromes and Hematopoietic Stem Cell Transplantation

Leukemia research, 2017-04, Vol.55, p.S27-S29

2017

Volltextzugriff (PDF)

453 IS DOSE-DEPENDENT THE RENAL PROTECTIVE EFFECT OF INTRAVENOUS SILDENAFIL AGAINST WARM ISCHEMIA: EXPERIMENTAL STUDY

European urology supplements : official journal of the European Association of Urology, 2010-04, Vol.9 (2), p.162-163

2010

Volltextzugriff (PDF)

501 Urological de novo malignancies after renal transplantation: Incidence and management

European urology supplements : official journal of the European Association of Urology, 2013-03, Vol.12 (1), p.e501-e502

2013

Volltextzugriff (PDF)

598 Is a short pulsatile hypothermic perfusion just before the transplant beneficial for the graft in the setting of warm ischemic kidneys?

European urology supplements : official journal of the European Association of Urology, 2016-03, Vol.15 (3), p.e598-e598

2016

Volltextzugriff (PDF)

606 Beneficial effect of a short-period of hypothermic pulsatile machine perfusion of warm ischemic kidneys just before the transplant. Experimental study

European urology supplements : official journal of the European Association of Urology, 2013-03, Vol.12 (1), p.e606-e607

2013

Volltextzugriff (PDF)

64 A retrospective time-dependent comparative analysis of the impact of lenalidomide on outcomes in lower risk MDS with chromosome 5q deletion

Leukemia research, 2011, Vol.35, p.S24-S24

2011

Volltextzugriff (PDF)

1 – 25 von 368

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(276)
Mit Volltextzugriff
(260)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(184)
Humans
(181)
Life Sciences & Biomedicine
(124)
Male
(100)
Female
(98)
Middle Aged
(81)
Hematology
(77)
Adult
(71)
Aged
(70)
Technology
(63)
Biological And Medical Sciences
(62)
Medical Sciences
(60)
Physical Sciences
(46)
Oncology
(38)
Hematologic And Hematopoietic Diseases
(37)
Adolescent
(34)
Physics
(33)
Engineering
(32)
Materials Science
(31)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

1 Laboratory presentation and morphological characteristics of myelodysplastic syndromes

1084 Self-expanding metallic ureteral stents and extra-anatomic bypasses. Are they really effective for resolution of complex ureteral obstruction in the long-term?

117 A PHASE 3 STUDY OF LENALIDOMIDE VERSUS PLACEBO IN RBC TRANSFUSION-DEPENDENT (TD) PATIENTS WITH LOWER-RISK MDS WITHOUT DEL(5Q) UNRESPONSIVE OR REFRACTORY TO ERYTHROPOIESIS-STIMULATING AGENTS (ESAS)

118 A PHASE 2 STUDY OF AZACITIDINE AND EPOETIN-BETA IN UNTREATED RBC-TRANSFUSION DEPENDENT LOWER-RISK MDS PATIENTS

163 - DNA Repair Genes Transcriptome in Chronic Myelomonocytic Leukemia

171 A TWO-STEP APPROACH FOR THE ANALYSIS OF SPLICING GENES IN MYELODYSPLASTIC SYNDROMES WITH RING SIDEROBLASTS

First clinical implantation of the BCM 3.5 ventricular assist device (VAD)

206 IMPACT OF TP53 MUTATION ON OUTCOME OF MDS PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANT (HSCT). GESMD STUDY

207 HIGH RISK MDS PATIENTS SUITABLE FOR ALLOGENEIC TRANSPLANT: IMPACT ON TREATMENT SELECTED (AZA OR CHEMOTHERAPY) ON OUTCOME. SINGLE EXPERIENCE CENTER

211 SPANISH REGISTRY OF ERYTHROPOIETIC STIMULATING AGENTS STUDY: THE LARGEST RETROSPECTIVE STUDY OF ESAS FOR THE TREATMENT OF ANEMIA IN LOWER RISK MDS PATIENTS

244 MYELOFIBROSIS (MF) AS A PROGNOSTIC TOOL FOR OVERALL SURVIVAL IN MYELODYSPLASTIC SYNDROMES: A PROSPECTIVE EVALUATION INCLUDING MUTATIONAL ANALYSIS BY NEXT GENERATION SEQUENCING (NGS)

258 Down-regulation of DICER1, DROSHA and microRNAs in MSC from MDS compared to healthy controls

282 - Iron Overload Increases Oxidative Stress and Decreases Clonogenic Capacity of Cells in MDS Patients: Can be Restored after Deferasirox Treatment?

292 Analysis of renal tissue environment using quantitative proteomics techniques: Healthy tissue from donors vs healthy tissue from renal cell carcinoma kidneys

297 Prognostic impact of severe thrombocytopenia in low risk myelodysplastic syndrome

298 Chromosome 7 abnormalities in MDS

298 Utility of quantitative proteomics techniques to identify renal cell carcinoma biomarkers

A 3 Terminal Parallel Connected Silicon Tandem Solar Cell

308 HIDDEN MDS: A PROSPECTIVE STUDY TO CONFIRM OR EXCLUDE MDS IN PATIENTS WITH ANEMIA OF UNCERTAIN ETIOLOGY

41 - Chronic GVHD Could Ameliorate the Impact of Adverse Somatic Mutations in Patients with Myelodysplastic Syndromes and Hematopoietic Stem Cell Transplantation

453 IS DOSE-DEPENDENT THE RENAL PROTECTIVE EFFECT OF INTRAVENOUS SILDENAFIL AGAINST WARM ISCHEMIA: EXPERIMENTAL STUDY

501 Urological de novo malignancies after renal transplantation: Incidence and management

598 Is a short pulsatile hypothermic perfusion just before the transplant beneficial for the graft in the setting of warm ischemic kidneys?

606 Beneficial effect of a short-period of hypothermic pulsatile machine perfusion of warm ischemic kidneys just before the transplant. Experimental study

64 A retrospective time-dependent comparative analysis of the impact of lenalidomide on outcomes in lower risk MDS with chromosome 5q deletion

Suchergebnisse filtern